Therefore, the study concluded that targeted local radiotherapy with 213Bi-DOTA-substance P analogue may represent an innovative and effective treatment strategy for critically located malignant gliomas, because primarily non-operable gliomas may become resectable over the course of treatment. The gene discussed is TAC1; the disease is malignant glioma.